These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3748530)

  • 1. Ventricular arrhythmias following intravenous cancer chemotherapy. Arrhythmias and chemotherapy.
    Unverferth DV; Balcerzak SP; Leier CV; Neidhart JA
    Ohio State Med J; 1986 Aug; 82(8):551-3, 560. PubMed ID: 3748530
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute arrhythmogenicity of first-dose chemotherapeutic agents in children.
    Massin MM; Dresse MF; Schmitz V; Hoyoux C; Chantraine JM; Lepage P
    Med Pediatr Oncol; 2002 Aug; 39(2):93-8. PubMed ID: 12116056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Asymptomatic electrocardiographic abnormalities during antiblastic chemotherapy].
    Bottoni P; Bobba L; Ranieri MG; Croce M; Zaietta P; Provera F
    Minerva Med; 1983 Oct; 74(38):2211-8. PubMed ID: 6196689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac arrhythmias during cytotoxic chemotherapy: role of domperidone.
    Osborne RJ; Slevin ML; Hunter RW; Hamer J
    Hum Toxicol; 1985 Nov; 4(6):617-26. PubMed ID: 4077073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiotoxicity of drugs used in the treatment of malignant neoplasms].
    Ciubra-Niczewska E
    Pol Tyg Lek; 1983 Jan; 38(1):35-7. PubMed ID: 6866817
    [No Abstract]   [Full Text] [Related]  

  • 6. QT interval prolongation and cardiac dysrhythmia in a patient receiving amsacrine.
    Schwartz CL; Bender KS; Burke PJ; Kan JS; Civin CI
    Cancer Treat Rep; 1984; 68(7-8):1043-4. PubMed ID: 6547639
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer chemotherapy and cardiac arrhythmias: a review.
    Tamargo J; Caballero R; Delpón E
    Drug Saf; 2015 Feb; 38(2):129-52. PubMed ID: 25577497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arrhythmias and Other Electrophysiology Issues in Cancer Patients Receiving Chemotherapy or Radiation.
    Viganego F; Singh R; Fradley MG
    Curr Cardiol Rep; 2016 Jun; 18(6):52. PubMed ID: 27108362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute electrocardiographic changes induced by amsacrine.
    Shinar E; Hasin Y
    Cancer Treat Rep; 1984 Sep; 68(9):1169-72. PubMed ID: 6592038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electrocardiographic monitoring of patients receiving phase I cancer chemotherapy.
    Hersh MR; Linn W; Kuhn JG; Von Hoff DD
    Cancer Treat Rep; 1986 Mar; 70(3):349-52. PubMed ID: 3955546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Approaches to prevention of the middle to late phase adverse drug reactions in chemotherapy].
    Maeda Y; Sasaki T
    Gan To Kagaku Ryoho; 2002 Jul; 29(7):1292-9. PubMed ID: 12146014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Arrhythmia, conduction disturbance].
    Sasahara Y
    Nihon Rinsho; 2015 Feb; 73 Suppl 2():399-402. PubMed ID: 25831790
    [No Abstract]   [Full Text] [Related]  

  • 13. Cancer chemotherapy: intravenous administration.
    Berman A; Chisholm L; de Carvalho M; Piemme JA; Gorrell CR
    Cancer Nurs; 1993 Apr; 16(2):145-58. PubMed ID: 8477403
    [No Abstract]   [Full Text] [Related]  

  • 14. Present risk of anthracycline or radiation-induced cardiac sequelae following therapy of malignancies in children and adolescents.
    Chen C; Heusch A; Donner B; Janssen G; Göbel U; Schmidt KG
    Klin Padiatr; 2009; 221(3):162-6. PubMed ID: 19437364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Heart damage after treatment of neoplasms with cytostatics].
    Wilk J
    Pol Tyg Lek; 1983 Jul; 38(27):853-5. PubMed ID: 6361712
    [No Abstract]   [Full Text] [Related]  

  • 16. [Electrocardiographic changes caused by dysionia (hyperpotassemia) during antineoplastic treatment].
    Bottoni P; Volpato G
    Minerva Med; 1974 Apr; 65(26):1464-72. PubMed ID: 4831473
    [No Abstract]   [Full Text] [Related]  

  • 17. Cardiac dysfunction in cancer patients receiving paclitaxel.
    Valdés Olmos RA; ten Bokkel Huinink WW; Hoefnagel CA
    Eur J Nucl Med; 1998 Apr; 25(4):446-7. PubMed ID: 9643974
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intravenous hyperalimentation for cancer chemotherapy].
    Hioki K; Kojima Y; Boku T; Hiramatsu Y
    Nihon Rinsho; 1991 Nov; 49 Suppl():608-14. PubMed ID: 1798169
    [No Abstract]   [Full Text] [Related]  

  • 19. [Transition of criteria for the determination of efficacy of cancer chemotherapy].
    Koyama Y
    Gan To Kagaku Ryoho; 1986 Jan; 13(1):153-63. PubMed ID: 3942397
    [No Abstract]   [Full Text] [Related]  

  • 20. Severe ventricular dysrhythmias and silent ischemia during infusion of the antimetabolite 5-fluorouracil and cis-platin.
    Hrovatin E; Viel E; Lestuzzi C; Tartuferi L; Zardo F; Brieda M; Dametto E; Piazza R; Antonini-Canterin F; Vaccher E; Meneguzzo N; Nicolosi GL
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):637-40. PubMed ID: 16858245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.